Related Experiment Videos
Autoantibodies in inflammatory myopathies
1School of Pharmacy, Curtin University of Technology, Western Australia, Perth. tgarlepp@cc.curtin.edu.au
The American Journal of the Medical Sciences
|April 18, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
Clinical and experimental immunology·2014
Statin myotoxicity: a review of genetic susceptibility factors.
Neuromuscular disorders : NMD·2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
Neuromuscular disorders : NMD·2013
Evidence for high-fidelity timing-dependent synaptic plasticity of human motor cortex.
Journal of neurophysiology·2012
Resting Heart Rate, Electrocardiographic Markers of Atrial Cardiopathy, and All-Cause Mortality.
The American journal of the medical sciences·2026
Uncovering the Evidence Frontier Beyond the Lipid-Lowering Effects of PCSK9 Inhibitors in Heart Transplantation.
The American journal of the medical sciences·2026
Outcomes of acute myeloid leukemia patients admitted to the intensive care unit within 100 days of allogeneic hematopoietic stem cell transplantation.
The American journal of the medical sciences·2026
Association between reverse triiodothyronine and cardiac complications in patients with uncontrolled Graves' disease.
The American journal of the medical sciences·2026
The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.
The American journal of the medical sciences·2026
Auricular hematoma in antiquity: Possible surgical drainage in the hellenistic boxer at rest.
The American journal of the medical sciences·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026